Amid rising anxiousness over tariffs, Vanderbilt College Medical Heart has warned its suppliers that any sudden value hikes attributed to the levies shall be rejected except an organization can justify its transfer — and even then, it could not receives a commission.
The Trump administration’s tariffs on items from all over the world — in addition to its plans to impose steep tariffs on the pharma trade particularly — has alarmed the numerous firms that produce medicine and units, on condition that their provide chains typically depend on parts and substances made in quite a few international locations. In consequence, hospitals and well being plans are involved these value hikes might be handed on to them, though VUMC is taking a very aggressive stance, in response to trade sources.
“We wish to make it as clear as attainable that Vanderbilt College Medical Heart Well being System doesn’t intend to simply accept value changes on account of tariff changes. We anticipate our suppliers to honor their present pricing agreements,” wrote Teresa Dail, the chief provide chain officer on the tutorial medical middle, which relies in Nashville, in an April 16 letter.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
